Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian F Schoppmann

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Wiener Klinische Wochenschrift|September 5, 2024
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Wiener Medizinische Wochenschrift (1946)|March 20, 2013
Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in AustriaEvelyne Bareck, Ahmed Ba-Ssalamah, Thomas Brodowicz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2025
Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Cancers|October 23, 2021
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center AnalysisHannah C Puhr, Thorsten J Reiter, Mohamed El-Mahrouk, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2013
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancerMatthias Preusser, Anna S Berghoff, Ayseguel Ilhan-Mutlu, et al.
Annals of Surgery|January 26, 2022
The Impact of Ineffective Esophageal Motility on Patients Undergoing Magnetic Sphincter AugmentationGeorge N Baison, Anee S Jackson, Candice L Wilshire, et al.
European Surgery : ACA : Acta Chirurgica Austriaca|December 19, 2018
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expectedSonja Kappel-Latif, Johannes Zacherl, Michael Hejna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2022
Improving the Diagnostic Yield of High-Resolution Esophageal Manometry for GERD: The "Straight Leg-Raise" International StudyStefano Siboni, Ivan Kristo, Benjamin D Rogers, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Wiener Klinische Wochenschrift|September 5, 2024
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Wiener Medizinische Wochenschrift (1946)|March 20, 2013
Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in AustriaEvelyne Bareck, Ahmed Ba-Ssalamah, Thomas Brodowicz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2025
Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Cancers|October 23, 2021
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center AnalysisHannah C Puhr, Thorsten J Reiter, Mohamed El-Mahrouk, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2013
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancerMatthias Preusser, Anna S Berghoff, Ayseguel Ilhan-Mutlu, et al.
Annals of Surgery|January 26, 2022
The Impact of Ineffective Esophageal Motility on Patients Undergoing Magnetic Sphincter AugmentationGeorge N Baison, Anee S Jackson, Candice L Wilshire, et al.
European Surgery : ACA : Acta Chirurgica Austriaca|December 19, 2018
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expectedSonja Kappel-Latif, Johannes Zacherl, Michael Hejna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2022
Improving the Diagnostic Yield of High-Resolution Esophageal Manometry for GERD: The "Straight Leg-Raise" International StudyStefano Siboni, Ivan Kristo, Benjamin D Rogers, et al.
Pageof 15